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Abstract
Epistaxis is a common complaint in the general population, and
its treatment is a common procedure in emergency depart-
ments. In the COVID-19 era, procedures involving airway man-
agement are a particular risk for health care workers due to
the high virulence of the virus, the transmission through aero-
sol, and the risk of contagion from asymptomatic patients. In
this article, we propose a simple memorandum of clinical rec-
ommendations to minimize the risk of operator infection deriv-
ing from epistaxis management. The correct use of personal
protective equipment and strict compliance with the behavioral
guidelines are essential to reduce the potential risk of infection.
In particular, the use of filtering masks is strongly recommended
since all patients, including those referring for epistaxis, should
be treated as being COVID-19 positive in the emergency
department. The safety of health care workers is essential not
only to safeguard continuous patient care but also to limit virus
transmission.
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T
he outbreak of SARS-CoV-2 (COVID-19) in the city
of Wuhan, China, has evolved rapidly into a public
health crisis and has spread exponentially to other
parts of the world.1 Medical professionals caring for patients
with COVID-19 are at high risk of contracting the infection,
given its high virulence and the occurrence of contagion
from asymptomatic individuals.2 In Italy, the percentage of
health care workers infected by COVID-19 accounts for
about 10% of total patients.3 Procedures involving airway
management are a particular risk for the generation of aero-
sols or droplets laden with viral particles4; thus, specific
guidelines have been proposed for some aerosol-generating
procedures in hospitalized patients, such as tracheostomy.5,6
Among diseases requiring prompt treatment in the emer-
gency department (ED), epistaxis accounts for about 0.5% of
all ED visits and up to one-third of all otolaryngology-ED
procedures.7 In this article, we propose a simple memoran-
dum of clinical and behavior recommendations to minimize
the infection risk to health care workers involved in the treat-
ment of epistaxis in the ED.
Clinical Recommendations for Epistaxis
Personal Protection
As a general rule, all patients should be treated as being
COVID-19 positive, with health care workers using the
highest level of personal protective equipment (PPE). The
use of disposable equipment must be strictly recommended.
The use of filtering masks has been widely debated, and they
have demonstrated protection against aerosols. FFP3 (Europe)
or N99 (US) masks, which allow a minimum 99% filtration,
must be preferred to any other option.8 However, in case of
FFP3 mask absence, FFP2 or N95 masks can be used, covered
by a surgical mask.6 Cap and shoe covers are considered nec-
essary for safely dressing; eye protection through the use of
surgical goggles or a face shield is required; and the use of
double gown is preferable, where available. The use of double
nitrile gloves is recommended.3,6
Clinical Assessment
Before clinical procedures, all patients should be asked
about contacts at risk for COVID-19, fever, and respiratory
symptoms. Patients referencing sudden loss of smell and/or
taste should be considered at high risk for COVID-19 infec-
tion.9 Patients should wear a surgical mask covering the
mouth, if permitted by the clinical condition.
Prompt assessment of the severity of epistaxis should be
performed by a physician or a nurse in the ED to distinguish
patients who require prompt treatment from patients who do
not. Patients with prolonged bleeding, bleeding from both
sides of the nose or from the mouth, or any signs of acute
hypovolemia (tachycardia, syncope, orthostatic hypotension)
must be immediately treated, while patients with minor
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active bleeding should be addressed in a non-ED setting
where available.
General risk factors, such as high blood pressure, coagu-
lation factors, and ongoing therapies with anticoagulant or
antithrombotic drugs should be assessed.
Noninvasive intervention for nosebleed, including bidigi-
tal compression to the lower third of the nose for at least 15
minutes and administration of antifibrinolytic agents, such
as tranexamic acid, should be strictly recommended before
more invasive interventions are attempted.
Room Setting
Ideally, invasive treatment should be performed in the operat-
ing room (OR); however, well-demarcated areas within the ED
complex could be used if a conventional OR is not available.
Only an experienced clinical team with proper PPE should
be involved in the treatment of epistaxis, preferably including
a surgeon and a scrub nurse. Additional clinical staff should
be reserved for selected cases; an anesthetist should be
needed for patients requiring sedation in a conventional OR.
Treatment
Nasal packing or cautery should be performed in case of failed
noninvasive procedures (eg, compression) or in case of an
epistaxis episode judged to be life-threatening or unlikely to
respond to further compression alone. The use of resorbable
packing is recommended, if available, to reduce the need for
future visits, although experience and local availability of
resorbable packing may dictate the specific type of material
used.
Posterior epistaxis requiring sphenopalatine artery ligation
should be postponed until COVID-19 testing is performed.10
The use of local anesthetic atomized sprays should be
avoided, and soaked pledgets should be preferred.10 A suction
system should be used during the procedure within a closed
system with a viral filter.5
Postprocedure Recommendations
Postprocedural instructions regarding packing removal or
antibiotic prophylaxis should be provided to the patient to
reduce risks of recurrence and to optimize outcomes.
‘‘Gowning and degowning’’ procedures should be carefully
executed, as improper removal may result in operator contami-
nation.5 The postprocedure waste disposal and decontamination
of equipment need careful consideration to minimize contami-
nation of the environment. Personnel who handle the deconta-
mination of surgical equipment should also be appropriately
protected in standard PPE (Table 1).
Table 1. Clinical Recommendations for Epistaxis During the COVID-19 Pandemic.
Personal protection The use of disposable equipment must be strictly recommended.
FFP3 (Europe) or N99 (US) masks must be preferred.
FFP2 or N95 masks can be used in case of FFP3 mask absence, covered by surgical mask.
Cap and shoe covers, goggles, gown, and double nitrile gloves are strongly recommended.
Clinical assessment Control risk factors for nosebleed (blood pressure, coagulation factors, ongoing therapies with
antithrombotic or anticoagulant drugs).
Check fever, respiratory symptoms, and contact at risk.
Sudden loss of smell and/or taste should be investigated.
Dress patients with a surgical mask, if permitted.
Prompt assessment of the severity of nosebleed should be achieved immediately.
Noninvasive intervention (bidigital compression, administration of antifibrinolytic agents) is
recommended.
Room setting If conventional operating rooms are not available, well-demarcated areas within the emergency
department complex should be used.
Reduced and experienced clinical staff with proper personal protective equipment, including a
surgeon and a scrub nurse.
Treatment Avoid intervention unless necessary.
Nasal packing or cautery should be performed in case of failure of noninvasive procedures.
Resorbable packing should be recommended, if available.
Posterior epistaxis requiring sphenopalatine artery ligation should be postponed until COVID-19
testing is performed before surgical intervention.
Local anesthetic atomized sprays should be avoided and soaked pledgets preferred.
Suction system should be used during the procedure within a closed system with a viral filter.
Postprocedure recommendations Postprocedural instructions regarding packing removal or antibiotic prophylaxis should be
provided to the patient to reduce risks of recurrences and optimizing outcomes.
Gowning and degowning procedures should be carefully executed.
Personnel who handle the decontamination of surgical equipment should also be appropriately
protected in standard personal protective equipment.
2 Otolaryngology–Head and Neck Surgery
Discussion
Epistaxis is a common complaint in the general population,7
and its management should be considered a COVID-19 at-
risk procedure for several reasons. First, the surgical treat-
ment of epistaxis inevitably presents risk for droplet emis-
sion and viral transmission due to the close contiguity of
physician and patient. Moreover, nasal packing without
anesthesia or sedation may be painful; thus, the patient is
unable to control involuntary reflexes such as coughing.
Second, treatment of epistaxis needs prompt medical inter-
vention; as such, the presence of respiratory symptoms or
the close at-risk contacts of the patient may not be properly
investigated. Third, anterior nasal packing is generally per-
formed by nonspecialist physicians in various settings,
including the outpatient office or ED. Last, ‘‘doffing’’ pro-
cedures after epistaxis management may be considered a
risk for COVID-19 infection by accidental contact with the
contaminated PPE.10
Conclusion
Treatment of epistaxis is a frequent procedure performed in
the ED and exposes health care workers to risk of conta-
gion. Specific recommendations should be followed before,
during, and after epistaxis intervention to ensure the safety
of health care workers.
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